A Study of the Safety and Effectiveness of Two New Malaria Vaccines

NCT01003314 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine
BIOLOGICAL: AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge

Sponsor

University of Oxford